BDBM667093 N-{4-[7-(6-chloro-3-fluoropyridin- 2-yl)-1H,2H,3H-pyrido[3,4- b][1,4]oxazin-1-yl]pyridin-2-yl}-3- (4-methylpiperazin-1- yl)propanamide::US20240116947, Example 38

SMILES CN1CCN(CCC(=O)Nc2cc(ccn2)N2CCOc3cnc(cc23)-c2nc(Cl)ccc2F)CC1

InChI Key InChIKey=QIHMBZFPTHTCPU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667093   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667093(US20240116947, Example 38 | N-{4-[7-(6-chloro-3-fl...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent